BA
MEDP icon

Bridgewater Associates’s Medpace MEDP Stock Holding History

Bridgewater Associates’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.26M Sell
15,605
-25,530
-62% -$11.8M 0.03% 368
2026
Q1 		$19.8M Buy
41,135
+6,833
+20% +$3.5M 0.09% 157
2025
Q4 		$19.3M Buy
34,302
+1,072
+3% +$609K 0.07% 217
2025
Q3 		$17.1M Buy
+33,230
New +$14.5M 0.07% 229

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Bridgewater Associates's MEDP Position: Q2 2026 in Review

Bridgewater Associates reduced its Medpace (MEDP) stake by 62% in Q2 2026, selling an estimated $11.8M and leaving 15,605 shares worth $8.26M. The position accounts for 0.03% of the portfolio, ranked #368.

Bridgewater Associates first reported a position in MEDP in Q3 2025 and has held it in 4 quarters since. The position peaked at $19.8M in Q1 2026. 693 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Bridgewater Associates held 15,605 shares of Medpace worth $8.26M as of Q2 2026.
  • Bridgewater Associates sold 25,530 Medpace shares in Q2 2026, an estimated $11.8M.
  • Medpace made up 0.03% of Bridgewater Associates's portfolio in Q2 2026, its #368 holding.
  • Bridgewater Associates first reported a position in Medpace in Q3 2025 and has held it in 4 quarters since.
  • Bridgewater Associates's Medpace position peaked at $19.8M in Q1 2026.
  • 693 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.